Scynexis press release
WebbAll forward-looking statements contained in this press release speak only as of the date on which they were made. SCYNEXIS undertakes no obligation to update such statements … WebbSCYNEXIS to Present Ibrexafungerp Data at the 33rd Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) April 15-18 in Denmark. Read More > …
Scynexis press release
Did you know?
Webb20 okt. 2024 · Press Release SCYNEXIS Provides Corporate, Commercial and R&D Strategy Updates to Expand Market Potential for Its First-in-Class Antifungal Published: Oct. 20, … Webb20 okt. 2024 · SCYNEXIS has initiated the launch of its second commercial product in the U.S., BREXAFEMME ® (ibrexafungerp tablets). The U.S. Food and Drug Administration …
WebbSCYNEXIS Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update 03/30/23 GSK and SCYNEXIS Announce an Exclusive Agreement to … WebbPress Releases; Events ... SCYNEXIS Presents New Interim Positive Data of Ibrexafungerp for Refractory Vulvovaginal Candidiasis from Ongoing Phase 3 FURI Study at the …
WebbGSK and SCYNEXIS announce an exclusive agreement to commercialise and further develop B.. AQ. 03/30: Top Midday Gainers: MT. ... More press releases: Upcoming event … http://www.scynexis.com/news-media/press-releases?page=2
Webb31 mars 2024 · Statements contained in this press release regarding expected future events or results are "forward-looking statements" within the meaning of the Private …
Webb15 aug. 2024 · Aug 01, 2024 8:30am EDT SCYNEXIS Announces U.S. Food and Drug Administration Acceptance and Priority Review of the Supplemental New Drug … chan opthomoligist riWebb31 mars 2024 · Statements contained in this press release regarding expected future events or results are "forward-looking statements" within the meaning of the Private … harlingen texas demographics usWebb30 mars 2024 · SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties. SCYNEXIS retains rights to … harlingen texas demographicsWebbSCYNEXIS Announces Publication of Review Article Highlighting Ibrexafungerp as a Potential Novel Treatment for Invasive Mold Infections in the Journal of Fungi Nov 03, … chanopWebb13 apr. 2024 · SCYNEXIS, Inc. today announced the presentation of interim data across a diverse array of infection types from its ongoing Phase 3 FURI and CARES studies, as … harlingen texas directionsWebbSCYNEXIS, INC. : Press releases relating to SCYNEXIS, INC. Investor relations Nasdaq: SCYX Nasdaq chan optometryWebb2 juni 2024 · JERSEY CITY, N.J., June 02, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX ), a biotechnology company pioneering innovative medicines to … chan optometry markham